UA41873C2 - Композиція аерозолю, що знаходиться під тиском - Google Patents

Композиція аерозолю, що знаходиться під тиском

Info

Publication number
UA41873C2
UA41873C2 UA94005331A UA94005331A UA41873C2 UA 41873 C2 UA41873 C2 UA 41873C2 UA 94005331 A UA94005331 A UA 94005331A UA 94005331 A UA94005331 A UA 94005331A UA 41873 C2 UA41873 C2 UA 41873C2
Authority
UA
Ukraine
Prior art keywords
composition
under pressure
copolymers
aerosol under
amide
Prior art date
Application number
UA94005331A
Other languages
English (en)
Russian (ru)
Inventor
Нагарбхай Містрі Суреч
Суреч Нагарбхай Мистри
Гібсон Марк
Марк Гибсон
Original Assignee
Фізонз Плк
Физонз Плк
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27450754&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA41873(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB919120396A external-priority patent/GB9120396D0/en
Priority claimed from GB919120675A external-priority patent/GB9120675D0/en
Priority claimed from GB919124661A external-priority patent/GB9124661D0/en
Priority claimed from GB929203212A external-priority patent/GB9203212D0/en
Application filed by Фізонз Плк, Физонз Плк filed Critical Фізонз Плк
Publication of UA41873C2 publication Critical patent/UA41873C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Otolaryngology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Colloid Chemistry (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)

Abstract

Запропонована аерозольна композиція, яка знаходиться під тиском, містить зріджений гідрофторалкан, диспергований в ньому порошкоподібний медикамент і розчинний в зрідженому гідрофторалкані полімер. Полімер вибраний з групи, до якої входять полімери, що складаються з амідовмісних повторюваних структурних ланок, сополімери амідовмісних ланок і ланок складного ефіру карбонової кислоти, полівінілацетат і сополімери складних ефірів акрилової/метакрилової кислот.
UA94005331A 1991-09-25 1992-09-23 Композиція аерозолю, що знаходиться під тиском UA41873C2 (uk)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB919120396A GB9120396D0 (en) 1991-09-25 1991-09-25 Formulations
GB919120675A GB9120675D0 (en) 1991-09-28 1991-09-28 Formulation
GB919124661A GB9124661D0 (en) 1991-11-19 1991-11-19 Formulations
GB929203212A GB9203212D0 (en) 1992-02-14 1992-02-14 Pharmaceutical formulations
PCT/GB1992/001749 WO1993005765A1 (en) 1991-09-25 1992-09-23 Pressurised aerosol compositions

Publications (1)

Publication Number Publication Date
UA41873C2 true UA41873C2 (uk) 2001-10-15

Family

ID=27450754

Family Applications (1)

Application Number Title Priority Date Filing Date
UA94005331A UA41873C2 (uk) 1991-09-25 1992-09-23 Композиція аерозолю, що знаходиться під тиском

Country Status (29)

Country Link
US (1) US6641800B1 (uk)
EP (2) EP0534731A1 (uk)
JP (1) JP3142136B2 (uk)
KR (1) KR100275426B1 (uk)
CN (1) CN1050285C (uk)
AT (1) ATE132739T1 (uk)
AU (1) AU654397B2 (uk)
BG (1) BG61752B1 (uk)
BR (1) BR9206549A (uk)
CA (1) CA2119932C (uk)
CZ (1) CZ282506B6 (uk)
DE (1) DE69207606T3 (uk)
DK (1) DK0605578T4 (uk)
ES (1) ES2082507T5 (uk)
FI (1) FI110407B (uk)
GR (2) GR3019098T3 (uk)
HK (1) HK1005564A1 (uk)
HU (2) HUT67480A (uk)
IL (1) IL103238A (uk)
MX (1) MX9205483A (uk)
MY (1) MY108309A (uk)
NO (1) NO307124B1 (uk)
NZ (1) NZ244439A (uk)
RO (1) RO114735B1 (uk)
RU (1) RU2122852C1 (uk)
SK (1) SK279456B6 (uk)
TW (1) TW216442B (uk)
UA (1) UA41873C2 (uk)
WO (1) WO1993005765A1 (uk)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
US7105152B1 (en) 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
GB9214819D0 (en) * 1992-07-13 1992-08-26 Minnesota Mining & Mfg Valve assemblies
US5569450A (en) * 1993-03-17 1996-10-29 Minnesota Mining And Manufacturing Company Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid
AU679510B2 (en) * 1993-03-17 1997-07-03 Minnesota Mining And Manufacturing Company Aerosol formulation containing a diol-diacid derived dispersing aid
PT835098E (pt) 1995-06-27 2002-12-31 Boehringer Ingelheim Pharma Nova composicao farmaceutica estavel para a producao de aerossois sem gas propulsante
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US6039932A (en) * 1996-09-27 2000-03-21 3M Innovative Properties Company Medicinal inhalation aerosol formulations containing budesonide
US6126919A (en) 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US6946117B1 (en) 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
US6451285B2 (en) * 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US6136294C1 (en) * 1998-09-22 2002-09-24 Aeropharm Technology Inc Amino acid stabilized medical aerosol formulation
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
US6540982B1 (en) * 2000-01-25 2003-04-01 Aeropharm Technology Incorporated Medical aerosol formulation
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
PL358375A1 (en) * 2000-04-13 2004-08-09 Innovata Biomed Limited Medicaments for treating respiratory disorders comprising formoterol and fluticasone
US7442388B2 (en) 2000-05-10 2008-10-28 Weers Jeffry G Phospholipid-based powders for drug delivery
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
JP5392880B2 (ja) 2000-05-22 2014-01-22 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
DE60103527T2 (de) 2001-07-02 2005-06-16 Chiesi Farmaceutici S.P.A. Optimierte Tobramycin-Formulierung zur Aerosolbildung
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
US7368102B2 (en) 2001-12-19 2008-05-06 Nektar Therapeutics Pulmonary delivery of aminoglycosides
US7544177B2 (en) * 2002-01-24 2009-06-09 The Regents Of The University Of California Aerosol device to deliver bioactive agent
SE0200312D0 (sv) * 2002-02-01 2002-02-01 Astrazeneca Ab Novel composition
US7582284B2 (en) 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials
US7244742B2 (en) * 2002-08-17 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co Kg Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
GB0328630D0 (en) * 2003-12-10 2004-01-14 Medpharm Ltd Metered dose inhalation preparations
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
EP1732527A2 (en) * 2004-03-17 2006-12-20 Mpex Pharmaceuticals, Inc. Use and administration of bacterial efflux pump inhibitors
US7994225B2 (en) * 2004-03-17 2011-08-09 Rempex Pharmaceuticals, Inc. Bacterial efflux pump inhibitors for the treatment of ophthalmic and otic infections
US20070031343A1 (en) * 2005-08-04 2007-02-08 Bonfour Charles A Iii Flavored medicinal inhalant
FR2895260B1 (fr) * 2005-12-23 2009-02-20 Servier Lab Nouvelle composition pharmaceutique a base d'huile essentielle pour pulverisation nasale et/ou buccale
DE102006017320A1 (de) * 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
DK2425820T3 (en) 2007-02-11 2015-07-13 Map Pharmaceuticals Inc A method for the therapeutic administration of DHE in order to enable quick relief of migraine, while minimizing the adverse event profile
WO2008152398A2 (en) * 2007-06-14 2008-12-18 Cipla Limited Formulations for inhalation
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
CA2723183C (en) 2008-05-06 2014-04-22 Richard W. Ducharme Apparatus and methods for delivering therapeutic agents
EP2362766A2 (en) * 2008-11-04 2011-09-07 Cipla Limited Pharmaceutical aerosol composition
US8361054B2 (en) 2008-12-23 2013-01-29 Cook Medical Technologies Llc Apparatus and methods for containing and delivering therapeutic agents
US9101744B2 (en) 2009-05-29 2015-08-11 Cook Medical Technologies Llc Systems and methods for delivering therapeutic agents
US8118777B2 (en) 2009-05-29 2012-02-21 Cook Medical Technologies Llc Systems and methods for delivering therapeutic agents
CN102416179B (zh) 2010-09-28 2014-05-07 益得生物科技股份有限公司 用于哮喘的吸入性复方组合物
US11931227B2 (en) 2013-03-15 2024-03-19 Cook Medical Technologies Llc Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding
US9867931B2 (en) 2013-10-02 2018-01-16 Cook Medical Technologies Llc Therapeutic agents for delivery using a catheter and pressure source
GB201402513D0 (en) * 2014-02-13 2014-04-02 Cardiff Scintigraphics Ltd Pressurised metered dose inhalers and method of manufacture
EP3174522A1 (en) 2014-07-29 2017-06-07 3M Innovative Properties Company Method of preparing a pharmaceutical composition
CN108135840A (zh) * 2015-10-23 2018-06-08 巴斯夫欧洲公司 用于皮肤施用的控释香精的配制剂
US10702495B2 (en) 2017-02-20 2020-07-07 Nexien Biopharma, Inc. Method and compositions for treating dystrophies and myotonia
EP3750528A1 (en) 2019-06-11 2020-12-16 Nexien Biopharma, Inc. Compositions for treating dystrophies and myotonia
EP4161346A2 (en) 2020-06-05 2023-04-12 Cook Medical Technologies LLC Medical scopes for delivering therapeutic agents
WO2023287654A1 (en) 2021-07-14 2023-01-19 Cook Medical Technologies, LLC Systems and methods for preventing clogging of a delivery system
US12496429B2 (en) 2022-10-18 2025-12-16 Cook Medical Technologies Llc Systems and methods for delivering pressurized fluid to a target site alone or in conjunction with therapeutic agents

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US417295A (en) * 1889-12-17 Fabriken
AT274245B (de) 1967-05-17 1969-09-10 Verfahren zur Herstellung eines Spezialklebers für Verbandmaterialien
US4025635A (en) 1972-09-06 1977-05-24 Burroughs Wellcome Co. Cyclic sulphur compounds
CA1136547A (en) * 1979-03-08 1982-11-30 Song-Ling Lin Aerosol anesthetic compositions
EP0175671A1 (de) 1984-08-23 1986-03-26 Kuhlemann & Co. Pharmazeutische Zubereitung sowie Verfahren zum Darreichen dieser pharmazeutischen Zubereitung
WO1987005210A1 (fr) 1986-03-10 1987-09-11 Kurt Burghart Produit pharmaceutique et son procede de preparation
AU597049B2 (en) * 1986-03-10 1990-05-24 Kurt Burghart Pharmaceutical preparation containing nifedipine
US4752466A (en) 1987-08-31 1988-06-21 Johnson & Johnson Products, Inc. Thrombin aerosol
US5225183A (en) 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
GB8921222D0 (en) 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
IL95952A0 (en) 1989-10-19 1991-07-18 Sterling Drug Inc Aerosol composition for topical medicament
IE67185B1 (en) 1990-02-02 1996-03-06 Fisons Plc Propellant compositions
US6123924A (en) * 1991-09-25 2000-09-26 Fisons Plc Pressurized aerosol inhalation compositions
US5658549A (en) 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
US5874064A (en) * 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery

Also Published As

Publication number Publication date
CA2119932C (en) 2002-05-21
DE69207606T2 (de) 1996-06-27
ATE132739T1 (de) 1996-01-15
JPH07502262A (ja) 1995-03-09
DE69207606T3 (de) 2000-03-16
IL103238A (en) 1995-07-31
NO941077L (no) 1994-05-18
WO1993005765A1 (en) 1993-04-01
NO307124B1 (no) 2000-02-14
EP0605578A1 (en) 1994-07-13
EP0605578B2 (en) 1999-09-22
FI110407B (fi) 2003-01-31
HU210818A9 (en) 1995-08-28
HU9400853D0 (en) 1994-06-28
EP0534731A1 (en) 1993-03-31
MX9205483A (es) 1993-05-01
NO941077D0 (no) 1994-03-24
ES2082507T5 (es) 1999-11-16
EP0605578B1 (en) 1996-01-10
CA2119932A1 (en) 1993-04-01
CZ282506B6 (cs) 1997-07-16
SK34094A3 (en) 1994-11-09
KR100275426B1 (ko) 2001-03-02
HUT67480A (en) 1995-04-28
FI941388L (fi) 1994-03-25
GR3032103T3 (en) 2000-03-31
RO114735B1 (ro) 1999-07-30
FI941388A0 (fi) 1994-03-25
CZ69594A3 (en) 1995-11-15
SK279456B6 (sk) 1998-11-04
MY108309A (en) 1996-09-30
HK1005564A1 (en) 1999-01-15
NZ244439A (en) 1994-01-26
DK0605578T3 (da) 1996-03-25
CN1071832A (zh) 1993-05-12
ES2082507T3 (es) 1996-03-16
BR9206549A (pt) 1995-10-17
GR3019098T3 (en) 1996-05-31
US6641800B1 (en) 2003-11-04
BG61752B1 (bg) 1998-05-29
BG98681A (bg) 1995-02-28
AU2647192A (en) 1993-04-27
JP3142136B2 (ja) 2001-03-07
IL103238A0 (en) 1993-02-21
CN1050285C (zh) 2000-03-15
DE69207606D1 (de) 1996-02-22
TW216442B (en) 1993-11-21
DK0605578T4 (da) 2000-03-06
AU654397B2 (en) 1994-11-03
RU2122852C1 (ru) 1998-12-10

Similar Documents

Publication Publication Date Title
CA2113233A1 (en) Cosmetic mask
DE69207606D1 (de) Unter druck aerosolzusammensetzungen
SI0669129T1 (en) Expandable release controlled medicaments
WO1998005360A3 (de) Verwendung von (meth)acrylsäure-copolymeren zur erhöhung der permeabilität der schleimhaut
ES2188540T3 (es) Sustancia de revestimiento con una mezcla de, como minimo, un humectante y ureas y/o derivados de la urea como agente tixotropico.
JPS5626966A (en) Pressure-sensitive adhesive composition
EP0602617A3 (en) Superabsorbent structure
DE68912075D1 (de) Estergruppen enthaltende (Meth-)acrylsäureester, ihre (Co-)polymere, den (Co)polymer enthaltende Komposition und die Estergruppe aufweisende (Meth)acrylsäureester enthaltende Komposition.
GB9100097D0 (en) Biocompatible mouldable polymeric material
ES420051A1 (es) Procedimiento para la preparacion de pegamentos polimeros adhesivos por contacto.
EP0381030A3 (de) Wässriges Polyacrylat-System für die Schlusslackierung von Polyvinylchlorid-Oberflächen
WO2002060417A8 (de) Lagerstabiles haft- und bindemittel für pharmazeutische anwendungen
ATE223197T1 (de) Kosmetische oder pharmazeutische zusammensetzung enthaltend ein ester des dextrins und ein hydrophiles geliermittel
JPS5634777A (en) Pressure-sensitive adhesive composition for polyvinyl chloride
PL328043A1 (en) Thickening agent of the basis of polymers containing carboxyl end carboxyloamide drug
JPS56166281A (en) Pressure-sensitive adhesive composition
TH17959B (th) องค์ประกอบละอองพ่นอัดความดัน
TH13253A (th) องค์ประกอบละอองพ่นอัดความดัน
MY140633A (en) Resin composition, extruded article, and anti-static sheet